Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Total Liabilities
QFRTL385USNO • Economic Data from Federal Reserve Economic Data (FRED)
Latest Value
1,119,269.00
Year-over-Year Change
8.83%
Date Range
10/1/2000 - 1/1/2025
Summary
The Quarterly Financial Report (QFR) measures the total liabilities of U.S. pharmaceutical and medicine corporations. This metric provides insight into the financial health and debt levels of a crucial industry.
Analysis & Context
This economic indicator provides valuable insights into current market conditions and economic trends. The data is updated regularly by the Federal Reserve and represents one of the most reliable sources for economic analysis.
Understanding this metric helps economists, policymakers, and investors make informed decisions about economic conditions and future trends. The interactive chart above allows you to explore historical patterns and identify key trends over time.
About This Dataset
The QFR total liabilities trend tracks the aggregate debt, payables, and other financial obligations of corporations in the pharmaceuticals and medicines sector. It is a key indicator of the industry's financial position and can inform economic analysis and policy decisions.
Methodology
The data is collected through quarterly surveys of large U.S. corporations.
Historical Context
Policymakers and analysts use this metric to assess the financial stability and credit conditions in the pharmaceutical industry.
Key Facts
- The pharmaceutical industry is a major contributor to the U.S. economy.
- Total liabilities provide a snapshot of a company's financial obligations.
- Quarterly reporting allows for timely analysis of industry trends.
FAQs
Q: What does this economic trend measure?
A: The Quarterly Financial Report (QFR) total liabilities trend measures the aggregate debt, payables, and other financial obligations of U.S. pharmaceutical and medicine corporations.
Q: Why is this trend relevant for users or analysts?
A: This metric provides insight into the financial health and stability of the pharmaceutical industry, which is a critical sector for the U.S. economy.
Q: How is this data collected or calculated?
A: The data is collected through quarterly surveys of large U.S. corporations conducted by the U.S. Federal Reserve.
Q: How is this trend used in economic policy?
A: Policymakers and analysts use this metric to assess credit conditions and financial stability in the pharmaceutical industry, which can inform economic policy decisions.
Q: Are there update delays or limitations?
A: The QFR data is released on a quarterly basis, so there may be a short delay in the most recent information being available.
Related Trends
Quarterly Financial Report: U.S. Corporations: Wholesale Trade, Durable Goods: Net Working Capital
QFRNWC421USNO
Quarterly Financial Report: U.S. Corporations: Scientific Research and Development Services: All Other Nonoperating Income (Expense)
QFRD110547USNO
Chicago Fed Midwest Economy Index
MEIM683SFRBCHI
Quarterly Financial Report: U.S. Corporations: Telecommunications: All Other Noncurrent Assets
QFRD222517USNO
Contributions to the Chicago Fed Midwest Economy Index: Iowa Contribution: Construction Sector
CONSTIAM683SFRBCHI
Quarterly Financial Report: U.S. Corporations: Food: Income (Loss) from Operations
QFR104311USNO
Citation
U.S. Federal Reserve, Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Total Liabilities (QFRTL385USNO), retrieved from FRED.